Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $56.37 USD
Change Today -9.57 / -14.51%
Volume 34.5M
MYL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 8:10 PM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for mylan nv (MYL)

Year over year, Mylan N.V. has been able to grow revenues from $6.9B USD to $7.6B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 55.36% to 52.97%. This was a driver that led to a bottom line growth from $623.7M USD to $929.4M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Revenues6,106.36,750.26,856.67,646.5
Other Revenues23.545.952.573.1
TOTAL REVENUES6,129.86,796.16,909.17,719.6
Cost of Goods Sold3,541.93,780.53,796.14,050.2
GROSS PROFIT2,588.03,015.63,113.03,669.4
Selling General & Admin Expenses, Total1,169.71,287.51,300.91,558.8
R&D Expenses291.1388.9456.2563.9
OTHER OPERATING EXPENSES, TOTAL1,460.91,676.41,757.12,122.7
OPERATING INCOME1,127.11,339.21,355.91,546.7
Interest Expense-335.9-308.7-314.1-333.2
NET INTEREST EXPENSE-335.9-308.7-314.1-333.2
Income (Loss) on Equity Investments---16.8-22.4-91.4
Currency Exchange Gains (Loss)34.249.663.84.0
Other Non-Operating Income (Expenses)-14.8-30.0-16.879.9
EBT, EXCLUDING UNUSUAL ITEMS810.51,033.31,066.41,206.0
Merger & Restructuring Charges-57.1-182.3-239.1-187.6
Gain (Loss) on Sale of Investments-----0.1--
Other Unusual Items, Total-98.8-46.8-79.9-43.9
Legal Settlements-48.63.114.6-47.9
Other Unusual Items-34.0-8.3-76.531.7
EBT, INCLUDING UNUSUAL ITEMS654.6804.2747.3974.5
Income Tax Expense115.8161.2120.841.4
Minority Interest in Earnings-2.0-2.1-2.8-3.7
Earnings from Continuing Operations538.8643.0626.5933.1
NET INCOME536.8640.9623.7929.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS536.8640.9623.7929.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS536.8640.9623.7929.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYL:US $56.37 USD -9.57

MYL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,928 JPY -13.00
Becton Dickinson and Co $146.33 USD -0.97
Perrigo Co PLC $193.60 USD +7.10
Shire PLC 5,525 GBp +30.00
Sun Pharmaceutical Industries Ltd 820.50 INR -3.20
View Industry Companies
 

Industry Analysis

MYL

Industry Average

Valuation MYL Industry Range
Price/Earnings 31.1x
Price/Sales 3.5x
Price/Book 3.6x
Price/Cash Flow 37.1x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYLAN NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.